Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer.

Cancers (Basel) · 2021 · PMC8616420 · PMID 34830902

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

For intermediate risk patients, adjuvant RT was associated with a 46% reduction of recurrence and a significantly lower risk of disease progression at 5 years, although the improvement in overall survival did not reach statistical significance [ 26 , 27 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.